全膝关节置换术后静脉注射羧基麦芽糖铁是否能加速患者血红蛋白恢复?
该回顾性研究纳入263例单侧全膝关节置换术患者,研究组157例(2019年)术后第1天接受静脉羧基麦芽糖铁500 mg,对照组106例(2016年)未接受铁剂补充。术后5(+1)周研究组血红蛋白显著高于对照组(P < .001),且研究组术前与术后5周血红蛋白差值显著低于对照组(P < .001)。作者认为静脉羧基麦芽糖铁500 mg是安全补充铁剂的方法,可快速持续改善全膝关节置换术后血红蛋白水平,并需进一步研究更高剂量(1000 mg)的附加效应。
要点
- 研究组术后5(+1)周血红蛋白显著高于对照组(P < .001)。
- 研究组术前与术后5周血红蛋白差值显著低于对照组(P < .001)。
- 两组术后5(+1)周血红蛋白均仍低于术前(P < .001)。
核心结论
- 静脉羧基麦芽糖铁500 mg被作者认为是全膝关节置换术后安全补充铁剂、快速持续改善血红蛋白水平的方法。
- 作者提出需进一步研究更高剂量羧基麦芽糖铁(1000 mg)对血红蛋白恢复的附加效应。
研究设计与样本
- 回顾性研究,纳入263例接受单侧全膝关节置换术的患者,研究组157例(2019年)术后第1天接受静脉羧基麦芽糖铁500 mg,对照组106例(2016年)术后未接受羧基麦芽糖铁或其他铁剂补充。
- 术前(Pr-Hb)、术后第3天(Day3-Hb)和术后5(+1)周(Week5-Hb)记录血红蛋白水平,使用配对和非配对t检验进行统计分析。
主要发现
- 术前血红蛋白和术后第3天血红蛋白在对照组与研究组间具有可比性,而术后5(+1)周血红蛋白研究组显著更高(P < .001)。
- 术后第3天血红蛋白较术前下降值两组间具有可比性(P = 1.0)。
- 术后第3天至5周血红蛋白升高值研究组显著高于对照组(P < .001)。
- 术前与术后5(+1)周血红蛋白差值研究组显著低于对照组(P < .001)。
- 两组术后5(+1)周血红蛋白均仍低于术前(P < .001)。
局限性
- 作者提出需进一步研究更高剂量羧基麦芽糖铁(1000 mg)对血红蛋白恢复的附加效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Timely and effective iron supplementation may help reduce the incidence of postoperative anemia and its associated problems. In this study, we aim to assess the efficacy of intravenous ferric carboxy maltose (FCM) on improving hemoglobin(Hb) level posttotal knee arthroplasty (TKA). METHODS: We retrospectively reviewed 263 patients who had undergone unilateral TKA with 157 patients in the study group (year 2019) and 106 in the control group (year 2016). Patients in the study group received FCM (500 mg IV) on postoperative day 1, whereas patients in the control group did not receive FCM or any other iron supplementation postoperatively. Hb levels were recorded preoperatively (Pr-Hb), postoperatively on day 3 (Day3-Hb) and postoperatively at 5(+1) weeks (Week5-Hb). Statistical analysis was performed using student's paired and unpaired t-tests. RESULTS: Pr-Hb and Day3-Hb levels were comparable in the control and study group, while Week5-Hb levels were significantly higher (P < .001) in the study group. The drop in Hb at Day3 from preoperative values was comparable between the two groups (P = 1.0). The rise in Hb from Day3 to 5 weeks was significantly higher in the study group as compared to the control group (P < .001). The difference between Pr-Hb and Week5-Hb was significantly lower (P < .001) in the study group compared to the control group. However, Week5-Hb in both groups remained lower than Pr-Hb (P < .001) in all patients. CONCLUSION: Intravenous FCM (500 mg) was found to be a safe method of iron supplementation to improve hemoglobin levels rapidly and consistently, post-TKA. We need to further study the additive effect of higher dose FCM (1000 mg) on hemoglobin recovery.
引用
- Maniar AR, Mishra A, Sanghavi N, et al. Does Postoperative Intravenous Ferric Carboxymaltose Hasten the Recovery of Hemoglobin in Patients Post Total Knee Arthroplasty? J Arthroplasty. 2022. PMID: 35202759. doi:10.1016/j.arth.2022.02.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。